|By Marketwired .||
|December 5, 2013 11:42 AM EST||
LONG ISLAND, NY--(Marketwired - December 05, 2013) - AccuVein Inc. (www.accuvein.com) has been named an award finalist in the 2014 Prism Awards for Photonics Innovation in the Life Science and Biophotonics category. The competition recognizes new products and inventions that break with conventional ideas, solve problems, and improve life through the generation and application of light-based technologies, optics and photonics.
The AccuVein AV400 vein illumination device helps healthcare professionals locate veins by displaying a map of the patient's vasculature directly on the surface of the skin. Locating peripheral vasculature is invaluable in many medical procedures that require vein access or avoidance. Accessing a vein for IV starts, blood draw and sclerotherapy procedures, as well as avoiding veins in surgery and cosmetic procedures, are all important applications of the device.
"With such impressive products and such varied applications, selecting finalists was indeed challenging for the judges," said SPIE CEO Eugene Arthurs. "Competitors include larger, well-established companies as well as newer and smaller firms from throughout the world working in a wide variety of sectors. The broad range reflects the extensive reach and power of photonics in our lives, and is a tribute to the creativity of our extraordinarily entrepreneurial community."
"More than a billion venipunctures are performed annually and as many as 40% require multiple sticks. AccuVein's augmented reality technology projects a visible vein pattern, enabling clinicians to see the invisible," said AccuVein Vice President of Engineering Joe Zott. "Our selection as a Prism Award Finalist further validates the AV400 as the vein illumination tool of choice and solidifies AccuVein as a leader in medical imaging."
Entries are judged by an independent panel of experts including industry executives, leading academic researchers, venture capitalists and past Prism Award winners. Winners will be announced by industry leaders on February 6th during SPIE Photonics West in San Francisco at a gala banquet that has become one of the largest gatherings of CEOs and other VIPs in the photonics industry.
SPIE is the international society for optics and photonics, a not-for-profit organization founded in 1955 to advance light-based technologies. The Society serves more than 235,000 constituents from approximately 155 countries, offering conferences, continuing education, books, journals, and a digital library in support of interdisciplinary information exchange, professional networking, and patent precedent. SPIE provided over $3.2 million in support of education and outreach programs in 2012. Learn more at http://www.spie.org.
About Photonics Media
Photonics Media, a business unit of Pittsfield, Mass.-based Laurin Publishing Co. Inc., publishes Photonics Spectra, BioPhotonics, EuroPhotonics, Photonics Buyers' Guide and Photonics.com. With a collective subscriber base of more than 150,000 worldwide and more than 2 million website visits per year, Laurin Publishing's Photonics Media products and publications lead the photonics industry with editorial excellence and integrity-fostering a tradition of innovation and progress by sharing knowledge, insights and visions for the future. Learn more at http://www.photonics.com.
About AccuVein Inc. AccuVein Inc. is a leader in medical imaging. AccuVein is the world's only hand-held, non-contact vein illumination solution. It allows healthcare professionals to see a map of peripheral veins on the skin's surface with the goal of accessing or avoiding veins. It is built on AccuVein's proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. AccuVein devices are in use at 3,000 hospitals and available for sale in over 100 countries worldwide. To see a demonstration of AccuVein vein illumination, please visit http://www.accuvein.com.
The following files are available for download: